We are monitoring the impact of COVID-19 & Recession alarm on North America RIA Market Get in touch with us for detailed analysis Know More
Share on

North America Radioimmunoassay Market Research Report – Segmented By Type, End User, Application & Country (The United States, Canada & Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 3556
Pages: 142

North America RIA Market Size (2022 to 2027)

The North American Radioimmunoassay Market size was valued at USD 146.93 million in 2022 and is estimated to be growing at a CAGR of 3.22% to reach USD 172.16 million by 2027.

A Radioimmunoassay (RIA) is an in-vitro assay technique for measuring antigen concentrations in blood. The separation of protein from a mixture utilizing the specificity of antibody-antigen binding and quantifying protein using radioactivity is referred to as RIA. With antibodies, the approach is hypersensitive and can quantify minute amounts of hormone or medication levels.

The increased prevalence and incidence of cancer and infectious diseases and technological improvements are majorly driving the expansion of the radioimmunoassay market in the North American region. Due to the increasing cancer burden in North America, cancer tests must be updated to reflect national priorities.

Due to the pervasiveness of several pharmaceuticals and biotechnology firms, the North American radioimmunoassay (RIA) reagents and devices sector is governed by a U.S. province. At the same time, the rising need for early diagnostic procedures is expected to accelerate the radioimmunoassay market in North America. Furthermore, increased research and development to find a cure for infectious diseases and epidemic outbreaks and rising spending on healthcare infrastructure boosts the market growth.

However, the high cost of radioimmunoassay equipment and dangerous radioactive material, and ongoing advances in many other immunoassay processes are expected to stifle market expansion during the forecast period. Strict guidelines and regulatory standards for procedures, as well as a hefty setup cost, are market restraints. In addition, the market is expected to be constrained by a scarcity of skilled professionals. North American countries have endured and continue to suffer a significant economic and healthcare burden due to the high transmission rate and lack of treatment. Lack of information about innovations and radioimmunoassay in remote locations and the effectiveness of radioimmunoassay reagents and devices in diagnosing complicated illnesses are a few of the restraints to the market growth.

This research report on the North America radioimmunoassay market has been segmented and sub-segmented into the following categories:

By Type: 

  • Reagents and Kits
  • Analyzers

By End User: 

  • Hospitals
  • Pharmaceutical Industry and CRO
  • Clinical Diagnostic Laboratories

By Application: 

  • Research
  • Clinical Diagnostics

By Country: 

  • The United States
  • Canada
  • Rest of North America

Geographically, the North American region is currently the largest market for immunoassays in the world. Factors such as the availability of high-end healthcare infrastructure, the availability of immunoassay reimbursement, and the high prevalence of chronic illnesses are favorable factors to the market in this region.

The United States, followed by Canada, is expected to occupy the leading share in the North American radioimmunoassay market during the forecast period.

KEY MARKET PLAYERS:

A few of the noteworthy companies operating in the North America radioimmunoassay market profiled in this report are DIAsource Immunoassays SA, Beckman Coulter, IBL International, PerkinElmer, DRG International, MP Biomedicals LLC, Cisbio, Euro Diagnostica AB, DiaSorin S.p.A, EMD Millipore, Izotop, Berthold Technologies GmbH & Co. KG and Stratec Biomedical AG.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Reagents and Kits                

                                5.1.3 Analyzers 

                                5.1.4  Y-o-Y Growth Analysis, By Type    

                                5.1.5  Market Attractiveness Analysis, By Type  

                                5.1.6  Market Share Analysis, By Type    

                5.2 End User                      

                                5.2.1 Introduction           

                                5.2.2 Hospital    

                                5.2.3 Pharmaceutical Industry and CRO 

                                5.2.4 Clinical Diagnostic Laboratories       

                                5.2.5 Y-o-Y Growth Analysis, By End User             

                                5.2.6 Market Attractiveness Analysis, By End User           

                                5.2.7 Market Share Analysis, By End User             

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Research  

                                5.3.3 Clinical Diagnostics               

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5  Market Attractiveness Analysis, By Application      

                                5.3.6  Market Share Analysis, By Application       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By End User

                                                6.1.3.4 By Application

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By End User

                                                6.1.4.4 By Application

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By End User

                                                6.1.5.4 By Application

                6.2 United States                            

                6.3 Canada                         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 DIAsource ImmunoAssays SA                             

                                8.1.1 Overview 

                                8.1.2 Type Analysis         

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Beckman Coulter                     

                8.3 IBL International                       

                8.4 PerkinElmer                               

                8.5 DRG international                    

                8.6 MP Biomedicals                        

                8.7 Cisbio                            

                8.8 Euro Diagnostica AB                

                8.9 DiaSorin                       

                8.10 Stratec Biomedical                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. North America Radioimmunoassay Market, By Type, From 2022 - 2027 (USD Million)
  2. North America Reagents and Kits Market, By Region, From 2022 - 2027 (USD Million)
  3. North America Analyzers Market, By Region, From 2022 - 2027 (USD Million)
  4. North America Radioimmunoassay Market, By End User, From 2022 - 2027 (USD Million)
  5. North America Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  6. North America Pharmaceutical Industry and CRO Market, By Region, From 2022 - 2027 (USD Million)
  7. North America Academics Market, By Region, From 2022 - 2027 (USD Million)
  8. North America Clinical Diagnostic Laboratories Market, By Region, From 2022 - 2027 (USD Million)
  9. North America Radioimmunoassay Market, By Application, From 2022 - 2027 (USD Million)
  10. North America Research Market, By Region, From 2022 - 2027 (USD Million)
  11. North America Clinical Diagnostics Market, By Region, From 2022 - 2027 (USD Million)
  12. United States Radioimmunoassay Market, By Type, From 2022 - 2027 (USD Million)
  13. United States Radioimmunoassay Market, By End User, From 2022 - 2027 (USD Million)
  14. United States Radioimmunoassay Market, By Application, From 2022 - 2027 (USD Million)
  15. Canada Radioimmunoassay Market, By Type, From 2022 - 2027 (USD Million)
  16. Canada Radioimmunoassay Market, By End User, From 2022 - 2027 (USD Million)
  17. Canada Radioimmunoassay Market, By Application, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample